Drugs News and Research

RSS

National Institutes of Mental Health awards $8M for HIV research

A multidisciplinary research team at the Johns Hopkins University School of Medicine has been awarded $8 million in funding by the National Institutes of Mental Health to develop methods to rid the body of HIV.

20 Jan 2010

SRA International awarded MARCS Integration Contract

SRA International, Inc., a leading provider of technology and strategic consulting services and solutions to government organizations and commercial clients, today announced that, on behalf of the Food and Drug Administration (FDA), the Department of the Interior/National Business Center/Acquisition Services Directorate-Herndon has awarded SRA the Mission Accomplishment and Regulatory Compliance Services (MARCS) Integration Contract (MIC).

19 Jan 2010

CytoDyn commences enrollment in Cytolin clinical trial

Following approval of the Institutional Review Board, CytoDyn, Inc. has discharged its duty to register a clinical trial of Cytolin®, the Company’s lead product, with the government’s website at www.clinicaltrials.gov, ID NCT01048372. The public has online access to this federal database, which describes the key elements of clinical trials and their status.

19 Jan 2010

Researchers propose a new model for breast cell differentiation

A study by researchers at Tufts University School of Medicine, the Sackler School of Graduate Biomedical Sciences at Tufts, and Tufts Medical Center improves our current understanding of the origins of breast cancer. The

19 Jan 2010

Repeated exposure to tobacco smoke makes lung cancer much worse

Repeated exposure to tobacco smoke makes lung cancer much worse, and one reason is that it steps up inflammation in the lung. Scientists at the University of California, San Diego School of Medicine have found that mice with early lung cancer lesions that were repeatedly exposed to tobacco smoke developed larger tumors - and developed tumors more quickly - than unexposed animals.

19 Jan 2010

Novartis obtains exclusive worldwide rights to develop and commercialize Chiasma's TPE technology

Chiasma, Inc., a privately held biopharma company, announced today that it has granted Novartis an option to obtain exclusive worldwide rights to develop and commercialize the Company's Transient Permeability Enhancer (TPE) technology for use with certain related small molecule products either in development or currently marketed by Novartis.

19 Jan 2010

Filmmaker conducts workshops to promote happiness and positive thinking in community

Working in conjunction with the New York City Department of Parks & Recreation, author and documentary filmmaker Lisa Cypers Kamen will be presenting her acclaimed Harvesting Happiness Workshops to seniors and at-risk youth in New York City this week.

19 Jan 2010

Perseid Therapeutics to co-develop and commercialize next-generation CTLA4-Ig therapeutics

Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its majority-owned subsidiary, Perseid Therapeutics LLC, achieved a preclinical milestone under its collaboration with Astellas Pharma Inc. to co-develop and commercialize next-generation CTLA4-Ig therapeutics.

19 Jan 2010

New issue from Annals of Internal Medicine

Prescriptions of some opioids, such as oxycodone, have increased significantly over the past decade. As long-term opioid therapy for chronic noncancer pain becomes more common, the deaths associated with opioids increase.

19 Jan 2010

New functions in an enzyme can develop through point mutation

A new study by a research team at Uppsala University shows how new functions can develop in an enzyme. This can explain, for example, how resistance to toxins can occur so simply. The findings are now being published in the Journal of Biological Chemistry.

19 Jan 2010

SAMHSA report indicates one quarter of adolescent girls were involved in serious fights in the past year

A report by the Substance Abuse and Mental Health Services Administration (SAMHSA) indicates that, in the past year, one quarter (26.7 percent) of adolescent girls participated in a serious fight at school or work, group-against-group fight, or an attack on others with the intent to inflict serious harm.

19 Jan 2010

Genetic map of Artemisia will accelerate breeding to address increased demand for malaria treatments

Plant scientists at the University of York have published the first genetic map of the medicinal herb Artemisia annua. The map is being used to accelerate plant breeding of Artemisia and rapidly develop the species into a high-yielding crop. This development is urgently needed to help meet escalating demand for effective malaria treatments.

19 Jan 2010

The Methodist Hospital initiates program on nanotechnology in orthopedics and spine surgery

A new research program at The Methodist Hospital in Houston is the nation's first dedicated solely to advancing nanotechnology in orthopedics and spine surgery.

19 Jan 2010

EMBL-EBI hosts drug discovery database

ChEMBLdb, a vast online database of information on the properties and activities of drugs and drug-like small molecules and their targets, launches today with information on over half a million compounds. The data lie at the heart of translating information from the human genome into successful new drugs in the clinic.

19 Jan 2010

Scientists launch NEWMEDS project to develop drugs for schizophrenia and depression

An international consortium of scientists, led by H. Lundbeck A/S and King's College London, has launched one of the largest ever research academic-industry collaboration projects to find new methods for the development of drugs for schizophrenia and depression.

19 Jan 2010

Lighter sedation during spinal anesthesia reduces postoperative delirium in elderly patients

A recent study, published in the January issue of Mayo Clinic Proceedings, demonstrates that in elderly patients undergoing hip fracture repair under spinal anesthesia with propofol sedation, the prevalence of delirium can be decreased by 50 percent with light sedation, compared to deep sedation.

19 Jan 2010

New type of fat-producing cells may speed up treatments for muscular dystrophy and fibrosis

A team of University of British Columbia researchers has identified fat-producing cells that possess "dual-personalities" and may further the development of treatments for muscle diseases such as muscular dystrophy and fibrosis.

19 Jan 2010

Study examines how opioid overdose differs by prescribed dose for chronic pain conditions

More and more Americans with chronic pain not caused by cancer are taking medically prescribed opioids like Oxycontin (oxycodone) and Vicodin (hydrocodone). The January 19 Annals of Internal Medicine features the first study to explore the risk of overdose in patients prescribed opioids for chronic noncancer pain in general health care.

19 Jan 2010

"Nanoburrs" for treating cardiovascular diseases

Researchers at MIT and Harvard Medical School have built targeted nanoparticles that can cling to artery walls and slowly release medicine, an advance that potentially provides an alternative to drug-releasing stents in some patients with cardiovascular disease.

19 Jan 2010

U-M's tailored treatment more effective against heart attacks

A new study by the University of Michigan Medical School and VA Ann Arbor Health System challenges the medical thinking that the lower the cholesterol, the better.

19 Jan 2010

Drugs News and Research

National Institutes of Mental Health awards $8M for HIV research

SRA International awarded MARCS Integration Contract

CytoDyn commences enrollment in Cytolin clinical trial

Researchers propose a new model for breast cell differentiation

Repeated exposure to tobacco smoke makes lung cancer much worse

Novartis obtains exclusive worldwide rights to develop and commercialize Chiasma's TPE technology

Filmmaker conducts workshops to promote happiness and positive thinking in community

Perseid Therapeutics to co-develop and commercialize next-generation CTLA4-Ig therapeutics

New issue from Annals of Internal Medicine

New functions in an enzyme can develop through point mutation

SAMHSA report indicates one quarter of adolescent girls were involved in serious fights in the past year

Genetic map of Artemisia will accelerate breeding to address increased demand for malaria treatments

The Methodist Hospital initiates program on nanotechnology in orthopedics and spine surgery

EMBL-EBI hosts drug discovery database

Scientists launch NEWMEDS project to develop drugs for schizophrenia and depression

Lighter sedation during spinal anesthesia reduces postoperative delirium in elderly patients

New type of fat-producing cells may speed up treatments for muscular dystrophy and fibrosis

Study examines how opioid overdose differs by prescribed dose for chronic pain conditions

"Nanoburrs" for treating cardiovascular diseases

U-M's tailored treatment more effective against heart attacks

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News